There are many compelling reasons for reducing fresh gas flow (FGF) rates when using volatile anaesthetics. All of the dose of an intravenous agent injected into a patient enters the patient. In contrast, the quantity of an inhaled agent entering the circulation may be only a fraction of the amount that is delivered to the breathing system. Any excess administration represents waste with both cost and environmental consequences 1, 2 .
End-tidal control (ETc) functionality, which may influence FGF rates, has recently been introduced in Aisys ® (GE Healthcare, Madison, WI, USA) anaesthesia machines in many parts of the world outside North America 2, 5, 6 . This is a form of automated agent delivery whereby the user specifies a desired end-tidal agent (and oxygen) 'target' and a minimum FGF rate (not less than 0.5 l/minute). The machine then adjusts vapour delivery from an out-of-circuit electronic vapouriser along with the flow rates of oxygen (O 2 ) and the chosen carrier gas (either air or nitrous oxide) to achieve the desired targets in the end-tidal gas mixture. This system is similar to 'target controlled infusion' (TCI) for intravenous agents such as propofol. When the first five minutes after a change in target is excluded, this system has been shown to maintain end-tidal concentrations within 10% of the set target for 98% of time 6 . Automated vapour control systems are available on other anaesthetic machines, such as the Dräger Zeus ® (Dräger, Lubeck, Germany) and have been shown to significantly reduce flow rates and hence volatile agent consumption 7 .
The Aisys ® (with or without ETc) has electronic gas flow controls. The user adjusts total fresh gas flow, percentage O 2 and vapour concentration in the fresh gas mix by selecting the relevant parameter and adjusting the control wheel to set the desired value. Our machines are set to deliver 6 l/minute of 100% O 2 at the start of a case.
We have been observing flow rates in our hospital at intervals since 2001. We have logged data over extended periods directly from Datex ADU Carestation ® anaesthetic machines (GE Healthcare, Madison, WI, USA) (ADU) and have previously reported the reduction in flow rates and the consequent savings seen between 2001 and 2006 3, 4 . Since that time we have continued to collect data from our ADUs at intervals, collected data from other hospitals in New Zealand for comparison and installed several Aisys ® machines with ETc.
The primary aim of this paper is to describe the effect of the introduction of the Aisys ® with automated control of end-tidal vapour concentration on FGF rates in our department. To provide a context for these results we have updated our previously published data and provided comparative data from other New Zealand hospitals. We were interested in comparative data from other hospitals both for 'benchmarking', particularly because one of the other hospitals studied has a reputation for the use of low flows and closed circuits. Another aim of the paper is to report the results of an intradepartmental survey into attitudes and concerns related to the introduction of ETc facility. This paper is not intended as a comprehensive review or analysis of the function of the ETc system implemented in the Aisys ® ; instead it is a presentation of data collected as part of an ongoing audit.
METHODS
Data for this ongoing audit were collected in accordance with Rule 2 of the New Zealand Health Information Privacy Code. The study was approved by the New Zealand Multi-centre Ethics Committee (reference number MEC/06/06/058). As outlined by the New Zealand National Ethics Committee Guidelines 7 , ethical approval and informed consent were not required for the survey.
We installed Aisys ® machines with ETc in all eleven operating theatres in one theatre suite at Christchurch Hospital in March 2011. These theatres constitute around one-third of our anaesthetising locations and include the bulk of our major and acute surgery. Our department has 65 specialist anaesthetists and 25 trainees.
We used our previously published data, collected in 2001 and 2006, for comparison. Data were collected from ADU machines in our hospital in 2009 and in two other hospitals from 2007 to 2009 using the methods described in our previous paper 4 . In summary, data collection and analysis from the ADU involved collecting data exported by the ADU to a computer every ten seconds over a number of weeks. Each dataset was analysed offline by first finding the time intervals during which the vapouriser setting was greater than zero. From this subset, the mean FGF during the time vapour was being administered was calculated. The samples were sorted into bins to allow construction of flow distribution curves. For the ADU data these bins were 0.0 to 0.5 l/minute; 0.5 to 1.0 l/ minute; 1.0 to 1.5 l/minute; 1.5 to 2.0 l/minute; 2.0 to 2.5 l/minute; 2.5 to 3.0 l/minute; 3.0 to 4.0 l/minute; 4.0 to 5.0 l/minute; 5.0 to 6.0 l/minute; 6.0 to 8.0 l/ minute; 8.0 to 10.0 l/minute and >10 l/minute 4 . Data were collected over a six-month period in 2007 from two machines at Middlemore Hospital, an 800-bed tertiary hospital in Manukau City in the southern part of the Greater Auckland region. We also collected data from a single machine at North Shore Hospital in 2009. This is a 300-bed, nine operating room hospital providing secondary level care in Takapuna City in the north of Auckland. Prior to commencing data collection, anaesthetists at both hospitals were advised that flow rate data were to be collected over an extended period. There was no further reminder that the study was occurring. In these two hospitals, anaesthetic machines were moved between theatres as needed to fill gaps for servicing, since all machines and monitors are standardised. This means that over an extended period a given machine is used in a range of locations. In contrast, in our institution in Christchurch, a specific machine is assigned to a given location and a pool of 'spare machines' act as backups. Thus, data from an individual machine represents a particular anaesthetising location. Results from all three hospitals were combined with older data from Christchurch, reported to the departments involved at the end of each collection period and presented at regional meetings.
Data collection from the Aisys ® requires a different approach from that used with the ADU. The machine keeps detailed event logs which can be downloaded. One file records all user key-presses and interactions with the machine. The log retains the last 4000 such events. From this log, the times at which the vapouriser and flow rates are adjusted can be extracted and the length of time spent at each flow rate calculated. From this information, pooled mean flow rates, flow rate distributions and the proportion of time spent in 'fresh gas' (conventional) and 'endtidal' (automated) control mode can be calculated. We chose to adjust the bins used for the cumulative flow distribution from that used for the ADU data in order to provide higher resolution at lower flow rates. The bins used were 0.0 to 0.4 l/minute; 0.4 to 0.6 l/minute; 0.6 to 0.8 l/minute; 0.8 to 1.0 l/minute; 1.0 to 1.25 l/minute; 1.25 to 1.50 l/minute; 1.50 to 1.75 l/minute; 1.75 to 2.0 l/minute; 2.0 to 3.0 l/minute; 3.0 to 4.0 l/minute; 4.0 to 6.0 l/minute; 6.0 to 8.0 l/ minute and >8.0 l/minute.
The key-press log does not include the control adjustments made by the machine in ETc mode. For each period in ETc a separate detailed log is kept. These logs record, at ten-second intervals, the FGFs, vapouriser setting, inspired and expired vapour concentrations and an extensive range of other information. From these files we extracted the FGF rate at the times the set end-tidal target was above zero and vapour was being delivered, which allowed us to derive pooled mean FGFs and flow rate distributions.
The Aisys ® machines were introduced in April 2011. We collected data in June 2011, December 2011 and June 2012. Results from each set of data were fed back to our department within six weeks of the end of each data collection period. Based on early practical experience and following the June 2011 data collection, we made a number of changes to the default configurations. In particular, the default minimum flow rate with sevoflurane was changed from 2.0 l/ minute to 0.5 l/minute. We have not collected data from operating theatres with a significant paediatric practice or from our cardiothoracic or neurosurgery operating theatres. The theatres observed have a broad mix of adult elective and acute surgery, are staffed by anaesthetists and trainees at all levels and have a broadly similar case mix to that at the time of our ADU data collection. Based on discussions and comments after the introduction of ETc and the 2011 audits, we conducted a simple online survey amongst members of our department to determine attitudes and issues with the use of ETc. The purpose of the survey was to identify issues and concerns with ETc and to help direct teaching. All questions were asked with a five point (1 to 5) scale and the numbers in the highest and lowest two categories (i.e. 1 and 2 or 4 and 5) combined. Table 1 gives details of the various data collection periods and also provides the pooled mean and median flow rates. The mean flow rate is an index of total consumption and, therefore, cost (and waste). The median flow rate can be considered a typical maintenance flow. Because the flow distributions are derived from bins of flow rate, the median flows are described as the range representing the upper and lower limits of the frequency distribution bin except where the median value falls on the boundary value. Figure 1 shows the cumulative flow patterns for the eight datasets. The data in Table 1 and Figure 1 show that overall flow rates have decreased over time, although there was an increase in mean and median flow rate after introduction of the Aisys ® . Figure 1 also shows that, except in the 2001 and the June 2011 datasets, flow rates are below 1.0 l/minute for around 70% of the time. Since the introduction of the Aisys ® we have also seen an increase in the proportion of time spent at higher flows. More time is spent at flows above 4.0 l/minute than in our 2001 data and the time above 2.0 l/minute is greater than all ADU datasets with the exception of 2001. The Christchurch 2009 results are very similar to those for Middlemore and North Shore hospitals.
RESULTS
The overall proportion of time spent in ETc mode with the Aisys ® machines was 34% in June 2011, 60% in December 2011 and 61% in June 2012. Figure 2 shows the mean flow rates from the Christchurch data. The mean flow rates in each control mode for the Aisys ® data are also shown. Figure 3 shows the corresponding flow rate distributions. There is an association between a reduction in flow rates and an increasing proportion of time spent in ETc mode. Figure 3 also shows that some practitioners are actively using low-flow techniques in manual, or fresh-gas control, mode with total FGF below 0.8 l/minute for 25% to 28% of the time in fresh gas mode.. \ In 2006 we found little difference between the four individual operating theatres with mean FGF rates between 1.16 and 1.48 l/minute. By contrast, mean FGF in the six theatres observed in June 2012 varied between 0.84 l/minute and 1.45 l/minute (mean 1.12, median 1.11). Median use of ETc by time was 70% (range 24% to 72%).
Survey results
The survey was voluntary and anonymous and completed by 68 of our 90 anaesthetists (75%). This included 18 of 25 trainees and 50 of 65 specialist anaesthetists.
ETc was used 'often' or 'most of the time' by 67% of respondents. The reasons most commonly selected for not using ETc were the need to teach trainees (47.7% 'relevant' or 'very relevant') and when using total intravenous anaesthesia (34.9% of respondents). Of the known problems with ETc, difficulty in changing agent during a case (39.7%) and poor performance with circuit leaks, such as an ill-fitting laryngeal mask airway (40.5%) were the major issues.
For users, the main advantages of ETc were better control of agent levels (75.3%) whilst allowing attention to be directed to other aspects of anaesthesia care (71%) and a perception of reduced workload (55.8%). Flow reduction was important to 74.9% of respondents.
DISCUSSION
The main objective of this paper is to describe our experience of the influence of automated endtidal vapour control, as implemented in the Aisys ® , on FGF rates in our institution. We have been auditing FGF rates intermittently over more than ten years and our historical data provide a context for observing the effect of introducing automated control of volatile agents. This differs from studies designed to explore specifically the effect of the introduction of the Aisys ® with and without ETc in use 2,6 .
The first finding of this ongoing audit of FGF rates is that mean flow rates at Christchurch Hospital continued to decrease between 2006 and 2009. We also found that flow rates at two other major metropolitan public hospitals in New Zealand also using the ADU were very similar. This suggests that in daily practice, with a wide range of practitioners at different levels of training and a broad patient mix, mean flow rates of around 1.3 l/minute with median flows in the range 0.5 to 1.0 l/minute are achievable targets.
The first set of data following introduction of the Aisys ® showed an increase in both mean and median FGF. Twelve months later these values had fallen to well below our 2009 'baseline'. The initial increase in FGF was driven by the increased amount of time spent at high flow rates when in fresh gas control mode, with around 20% of time in fresh gas control mode at or above 3 l/minute and 15% of time at or above 6 l/minute. We speculate this increase was due to the start-up configuration which requires the user to actively reduce FGF from the default initial value of 6 l/minute, in contrast to a needle valve based system which starts at zero.
We saw a dramatic fall in both mean and median FGF between June 2011 and June 2012. Over this time there was increased use of ETc mode. There have also been small changes in the flow rates seen in ETc mode (Figure 3 ). In New Zealand there have been no regulatory guidelines on FGF rates with sevoflurane for more than ten years. The Aisys ® machines were delivered with the default minimum FGF set at 2 l/minute with sevoflurane and 0.5 l for desflurane and isoflurane. This setting was changed to 0.5 l for all agents in August 2011. There was a left shift in the ETc flow in the December 2011 data, probably reflecting this change. There was a further upward shift for the most recent data, probably representing increased understanding of, and confidence in, the way ETc functions. There has been little change in the flow rates seen while in manual, or fresh gas control, mode. Since fresh gas control is used less than 40% of the time volatile agents are in use, a high proportion of this time will be in the early phases of anaesthesia when higher flow rates are commonly used.
Our data suggest that use of a system automatically controlling vapour concentration can lead to reduction in overall FGF. Although our data were collected as part of an audit and not under strictly controlled study conditions, this finding is consistent with other studies of the effect of automated vapour control on FGF 2, 6, 8 . We also found that flow rates were higher when the Aisys ® was used in manual (fresh gas control) mode than when using the ADU. There are a number of possible reasons for this difference, including the influence of different study periods and personnel, and users taking a more conservative approach when using newer, less familiar technology. Another possible explanation is that some features of electronic systems such as the GE Aisys ® and the Dräger Zeus ® , which have the capacity for automated control, may make using low flows 'manually' more challenging than with conventional systems. This hypothesis suggests that data directly comparing a given type of machine in 'manual' and 'automatic' mode may overstate the advantages of the automated mode and requires further investigation. Direct comparisons of our various datasets should take into consideration the many inherent limitations alluded to above. In particular, the samples from the two other hospitals were collected at different times and from a much smaller proportion of locations than the 2009 Christchurch data. Unlike the Christchurch data, we have no information about the case-or user-mix sampled. Nevertheless, these data were collected over a prolonged time period and represent several hundreds of hours of inhaled anaesthesia delivery and, therefore, provide a sample of practice at those hospitals. We have no data on the use of total intravenous anaesthesia at any of these hospitals but, anecdotally, in the 2006 to 2009 period total intravenous anaesthesia usage was significantly less than 5% at any of these hospitals. The patterns of flow are very similar to those recorded in Christchurch with similar technology. For the Aisys ® dataset we altered the boundaries for the bins for calculating the cumulative distributions. We did this because, for our 2009 data, 83% of the distribution occurs in the first three of 12 bins (<1.5 l/minute). The revised bins give greater resolution below 2 l/minute, but do mean that the curves and derived median values are not directly comparable. However, the differences in the patterns seen are distinctly different from the ADU datasets.
The main reason for encouraging flow rate reduction when volatile anaesthetics are used is to reduce waste and therefore costs and environmental pollution. Actual agent consumption is an alternative endpoint to flow rate and has been used in several studies. We chose to focus on FGF as this is the factor that users control directly, making it a better audit target, and is linearly related to consumption 9, 10 .
Based on annualised figures from the second half of 2012, our hospital currently spends US$320,000 on volatile anaesthetics per year. The mean flow rate in 2009 was 16% greater than the flow rate seen in June 2012, while the 2006 flow rate was 34% greater. An increase back to 2009 flow rates would increase costs by up to US$60,000 per annum (16% of $320,000) and an increase to 2006 flows would add US$125,000 each year. These potential savings are in addition to those arising from an ongoing decrease in the cost of sevoflurane and desflurane. Our survey was designed as an internal audit tool to explore attitudes to ETc and to allow us to focus education. It does, however, contain useful information that may be of wider interest. In particular, users felt that workload was reduced in ETc mode while allowing better control of agent levels. This matches the observations of Singaravelu and Barclay 6 , who found the number of user keypresses in the ETc group was half that seen in their manual control group. This is echoed in the work of Lortat-Jacob et al 8 , who found that users made fewer than half the number of adjustments when using an automated system compared with manual control with the Dräger Zeus ® , and that of Syroid et al, who found that a smart display system for intravenous agents allowed more accurate drug dosing while at the same time reducing perceived workload 11 . The inability to change agent during a case while continuing to use ETc was cited by some as a reason not to use ETc; Tay et al 2 suggest this limitation as a reason for their observed changes in sevoflurane and desflurane use.
Many studies have reported patterns of agent consumption over time. A number of studies have used measures of bulk consumption, such as bottles of liquid agent purchased 2,10,12 . These studies are able to track changes over time but contain little information on the nature of the practice underlying these changes. Other studies have used user-reported flow rates 13, 14 which, at best, will reflect maintenance flow rates, approximated by median flows. There are few studies that have tracked actual flow rates. Dexter et al 15 analysed actual flow rates over 12 months in a major US academic hospital and were able to explore the practice of individual providers. They found median flow rates of around 1.90 l/minute with desflurane and isoflurane and 2.15 l/minute with sevoflurane. The corresponding mean FGF rates were: desflurane 1.87 l/minute, isoflurane 1.89 l/minute and sevoflurane 2.49 l/minute. Less than 1% of time was spent at fresh gas flows below 0.8 l/minute. Lortat-Jacob et al 8 , exploring the effect of introducing Dräger Zeus ® , reported a mean flow of 1.40 l/minute in the 'manual control' group while Singaravelu and Barclay found a mean FGF of 1.50 l/minute in longer cases in their 'manual control' group 6 . These results are similar to our most recent ADU data.
Lubarsky et al 16 and Body et al 14 both used individual feedback to produce a reduction in FGF rates, while Dexter et al 15 suggested specific feedback strategies. Our changes have occurred without specific individualised feedback. We have previously speculated 4 that our locally developed system for forward prediction of inhaled anaesthetic levels 17 , which is very similar to the 'Vapor View' display of the recently released Perseus ® machine from Dräger, helped with a cultural shift, as users became more comfortable with lower flows. We also speculate that experience with our guidance system made users receptive to the ETc mode of the Aisys ® .
The disadvantages of high-flow volatile anaesthesia are well known. Suitable equipment for reduced flow rate anaesthesia (minimal leak machines and routine use of oxygen and agent analysers) have been widely available for many years and overcome perceived safety issues. Our experience suggests that it is possible to develop an environment where lower flow rates are normal. However, the regular and repeated publication of 'how to' articles on lowflow anaesthesia 18, 19 and reiteration of the advantages of low flow suggest there is still resistance in many centres to widespread adoption of lower flow rates. The availability of delivery systems such as the GE Aisys ® with ETc and the Dräger Zeus ® which automate this process may facilitate more general acceptance of lower FGF rates by overcoming the perceived complexity of flow reduction 2 .
In summary, this ongoing audit has shown that our FGF rates when inhaled agents are being delivered have decreased beyond the levels we reported previously. It also shows that three geographically separated New Zealand hospitals with similar anaesthetic equipment had very similar patterns of FGF. Since the introduction of anaesthesia machines that automate inhaled agent delivery, a further marked reduction in fresh gas flow rates has been seen. Users appreciated the reduction in workload provided by automated agent delivery.
